Beng Loong Isaac Tea, MD
Cardiovascular Disease · Minot, NDNPI 1013392356
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $28,738 of the $41,995 with a category attached, or 68.4%. Philips North America LLC accounts for 65.6% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2024 at $32,992 and has fallen 99.0% since, to $345 in 2025. Among cardiovascular disease clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $172.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$28K
- Edwards Lifesciences$4K
- Penumbra, Inc.$3K
- Medtronic$3K
- Shockwave Medical, Inc$2K
- Abbott$1K
- plus $1K from 13 others
What the payments were for
- Speaking & faculty fees$4,70011%
- Travel & lodging$28,73868%
- Food & beverage$8,55520%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 28 | $27,535 |
| Edwards Lifesciences | 30 | $4,336 |
| Penumbra, Inc. | 5 | $2,936 |
| Medtronic(2 entities) | 31 | $2,860 |
| Shockwave Medical, Inc | 89 | $1,777 |
| Abbott | 31 | $1,184 |
| Siemens Medical Solutions USA, Inc. | 11 | $344 |
| Boston Scientific | 3 | $271 |
| Abiomed | 5 | $239 |
| Heartflow, Inc. | 1 | $144 |
| Merck | 1 | $85 |
| Bolton Medical Inc | 1 | $65 |
| Actelion Pharmaceuticals US, Inc. | 1 | $57 |
| Pfizer | 2 | $38 |
| Lantheus Medical Imaging, Inc. | 1 | $36 |
| Cardiva Medical, Inc. | 1 | $29 |
| Stryker | 1 | $24 |
| Scpharmaceuticals Inc. | 1 | $20 |
| Cordis US CORP. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$19,564
- US Und$5,386
- RUBY Coil$2,742
- Edwards SAPIEN 3 Transcatheter Heart Valve$2,065
- RESOLUTE ONYX$1,664
- (BR0) Coronary Atherectomy$1,166
- CARDIOMEMS$407
- (BQ9) Coronary IVUS$326
- COREVALVE EVOLUT R$249
- FFRct$144
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$134
- CorPath Imaging System$126
- COMET$119
- Indigo System$117
- (6575) Coronary Undivided$114
- (6366) Sync$112
- CoreValve Evolut$110
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$105
How this compares
$41,995 in reported general payments places this provider in the 95th percentile of 35 cardiovascular disease providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 132 | $128,522 |
| EliquisApixaban | 88 | $87,730 |
| JardianceEmpagliflozin | 45 | $31,246 |
| XareltoRivaroxaban | 15 | $14,997 |
| BrilintaTicagrelor | 15 | $8,597 |
| Metoprolol Succinate | 366 | $5,940 |
| Bumetanide | 75 | $5,594 |
| Atorvastatin Calcium | 423 | $4,283 |
| ClopidogrelClopidogrel Bisulfate | 283 | $3,608 |
| Prasugrel Hcl | 50 | $3,040 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 24 | $2,532 |
| Rosuvastatin Calcium | 158 | $2,432 |
| Spironolactone | 203 | $1,419 |
| Furosemide | 258 | $1,334 |
| Potassium Chloride | 40 | $1,028 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $38 | $87,73088 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 35 cardiovascular disease providers in North Dakota.
Other cardiovascular disease in Minot
- Samir TurkMinot$6K
- Mir SublaMinot$5K
- Valentine ChikwenduMinot$3K
- Noah ChelliahGrand Forks$115K
- Hussain BasrawalaGrand Forks$40K
- Thomas HaldisFargo$37K
- Matthew GlogozaFargo$36K
- Mikhail KirnusGrand Forks$16K
- Timothy PansegrauBismarck$16K
- Jason GoFargo$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.